LAD 2 cells were plated in a 96-well V bottomed plate in imaging buffer and incubated at 37 °C for 10 min. Antagonists were then added as indicated and incubated with the cells at 37 °C for 5–10 min before the addition of agonists. Cells were then incubated at 37 °C for an additional 20 min before being centrifuged (2500RPM, 10 min, 4 °C) and the supernatants removed. Supernatants were incubated with substrate (2 mM 4-nitrophenyl N-acetyl-β-D-glucosaminide diluted in 0.2 M citrate buffer) for 2 h at 37 °C. The reaction was stopped by the addition of Tris-HCl (1 M, pH 9.0) and absorbance at 405 nm measured (Expert Plus Microplate reader, Biochrom Ltd). Spontaneous β-hexosaminidase release was determined by the addition of imaging buffer only. Total β-hexosaminidase content was determined by the addition of Triton X-100 (0.06 %) to lyse the cells. Background readings were determined for later subtraction from wells containing only release buffer and substrate. All test conditions were done in duplicate in a single experiment and each experiment repeated a minimum of three times. Average background values and average spontaneous β-hexosaminidase release values were subtracted from the reading for each well. Release was then expressed as a percentage of the average total β-hexosaminidase content determined from the Triton-treated wells. Results are displayed as mean ± SEM. For all statistical data comparisons, percentage values were log10 converted to transform the data before a one-way ANOVA with post hoc Tukey test was performed. In all figures, * = p < 0.05, ** = p < 0.01. The LDH cytotoxicity assays were conducted using a kit (Roche) as per the manufacturer’s instructions.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.